Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.
about
Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Phase I dose-escalation study ...... patients with advanced cancer.
@en
Phase I dose-escalation study ...... patients with advanced cancer.
@nl
type
label
Phase I dose-escalation study ...... patients with advanced cancer.
@en
Phase I dose-escalation study ...... patients with advanced cancer.
@nl
prefLabel
Phase I dose-escalation study ...... patients with advanced cancer.
@en
Phase I dose-escalation study ...... patients with advanced cancer.
@nl
P2093
P2860
P356
P1476
Phase I dose-escalation study ...... patients with advanced cancer.
@en
P2093
A Ajavon-Hartmann
I Genvresse
J E Grilley-Olson
S R Alberts
P2860
P2888
P304
P356
10.1038/BJC.2017.428
P407
P577
2018-01-18T00:00:00Z
P6179
1100468308